Easyfine Pharma Private Limited
Founded in 2019 and headquartered in Maharashtra, India.
2019 | Thane, Maharashtra (India) | Active
Easyfine Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -62.85%
- Profit Growth -1149.86%
- Ebitda 55.35%
- Net Worth -89.95%
- Total Assets -79.73%
About Easyfine Pharma
Easyfine Pharma Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 September 2019 (Five years and five months 17 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jai Sahu and Krishnkumar Gupta serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100MH2019PTC330539
- Company No.
330539
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Chemicals
Who are the key members and board of directors at Easyfine Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnkumar Gupta  | Managing Director | 13-Sep-2019 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jai Sahu | Director | 13-Sep-2019 | Current |
Financial Performance of Easyfine Pharma.
Easyfine Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 62.85% decrease. The company also saw a substantial fall in profitability, with a 1149.86% decrease in profit. The company's net worth observed a substantial decline by a decrease of 89.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Easyfine Pharma?
Unlock access to Easyfine Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Deenbandhu Arogya Seva Foundation
Jai Sahu and Krishnkumar Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Easyfine Pharma?
Unlock and access historical data on people associated with Easyfine Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Easyfine Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Easyfine Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.